TFRC and lymphoma: Our data suggested that CD8+ Tfr cells might engage with lymphoma B cells and DCs via ICOS/ICOSL interactions, potentially stabilising FOXP3 function but also increasing IL‐10 production by Tregs, enhancing suppressive potency.55, 56